Caroline Elaine Porter

Title: Innovations in Cancer Therapy by Caroline Elaine Porter

Introduction: Caroline Elaine Porter is a prominent inventor based in Houston, TX, known for her significant contributions to cancer therapy. With a total of two patents, she has made remarkable strides in the field of oncolytic virotherapy and immunotherapy. Her work focuses on developing innovative treatments that harness the power of viruses to combat cancer.

Latest Patents: Caroline's latest patents include groundbreaking research on oncolytic virotherapy with helper-dependent adenoviral-based vectors expressing immunomodulatory molecules. This patent discusses a combination therapy for cancer that utilizes an oncolytic virus, a virus comprising nucleic acid encoding an immunomodulatory factor, and at least one cell with a chimeric antigen receptor (CAR) specific for a cancer cell antigen. In particular embodiments, the virus includes nucleic acid encoding IL-12 and/or antagonist anti-PD-L1 antibody. Another patent focuses on oncolytic virotherapy and immunotherapy, emphasizing similar components and their potential to enhance cancer treatment.

Career Highlights: Caroline Elaine Porter is affiliated with Baylor College of Medicine, where she conducts her research and develops her innovative therapies. Her work has garnered attention for its potential to revolutionize cancer treatment and improve patient outcomes.

Collaborations: Caroline collaborates with esteemed colleagues in her field, including Masataka Suzuki and Amanda Rosewell Shaw. Their combined expertise contributes to the advancement of cancer therapies and the exploration of new treatment modalities.

Conclusion: Caroline Elaine Porter exemplifies the spirit of innovation in cancer therapy through her patents and research at Baylor College of Medicine. Her contributions are paving the way for more effective treatments and a brighter future for cancer patients.